GO:0097125 cyclin B1-CDK1 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097125 defines the cyclin B1-CDK1 complex, a heterodimeric serine/threonine kinase composed of the regulatory cyclin B1 subunit and the catalytic CDK1 subunit.
• Active cyclin B1-CDK1 first appears on centrosomes in prophase and continues to accumulate after centrosome separation to drive mitotic progression.
• The complex coordinates multiple mitotic events, including spindle checkpoint robustness, mitochondrial respiration, and anti-apoptotic signaling.
• Cyclin B1-CDK1 activity is spatially and temporally regulated by nuclear localization, upstream regulators, and oxidative stress.
• Dysregulated cyclin B1-CDK1 contributes to cancer, oocyte aneuploidy, and metabolic dysfunction, making it a high-value target for functional genomics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of cyclin B1-CDK1 complex biology in disease-relevant contexts.
Description
The cyclin B1-CDK1 complex (GO:0097125) is a protein complex consisting of cyclin B1 and cyclin-dependent kinase 1 (CDK1). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle, while cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. This complex is the master regulator of entry into and progression through mitosis, and its activity is tightly controlled in space and time. Researchers study GO:0097125 because its dysfunction is linked to cancer, oocyte aneuploidy, and metabolic disorders, and because it serves as a paradigm for cell-cycle kinase regulation. Understanding the composition, assembly, and regulation of the cyclin B1-CDK1 complex is therefore essential for both basic cell biology and translational research.
cyclin B1-CDK1 complex At A Glance
| GO ID | GO:0097125 |
|---|---|
| GO term | cyclin B1-CDK1 complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Serine/threonine kinase activity that drives mitotic entry and progression |
| Complex subunits | Cyclin B1 (regulatory) and CDK1 (catalytic) |
| Subcellular localization | Centrosomes, cytoplasm, nucleus, mitochondria |
| Cell cycle phase | G2/M transition and mitosis |
| Upstream regulators | Nuclear localization signals, oxidative stress, and checkpoint kinases |
What Is GO:0097125?
The cyclin B1-CDK1 complex is a heterodimeric protein complex in which the regulatory subunit cyclin B1 binds to and activates the catalytic subunit CDK1. Cyclin B1 abundance oscillates during the cell cycle, peaking in G2/M, and its binding to CDK1 is required for CDK1 kinase activity. The complex phosphorylates serine/threonine residues on target substrates to orchestrate mitotic entry, spindle assembly, chromosome segregation, and mitotic exit.
Why Is cyclin B1-CDK1 complex Important in Cell Biology?
The cyclin B1-CDK1 complex is essential for cell division and its deregulation is a hallmark of many cancers and developmental defects. It coordinates not only mitotic entry but also mitochondrial respiration, spindle checkpoint robustness, and anti-apoptotic responses, making it a central node in cell fate decisions. Because cyclin B1-CDK1 activity is required for proliferation, it is a prime target for cancer therapeutics and a key focus in reproductive biology and metabolic research.
• Drives mitotic entry and progression by phosphorylating key substrates.
• Ensures robust spindle checkpoint signaling by facilitating MAD1 release from nuclear pores.
• Coordinates mitochondrial respiration for G2/M progression.
• Phosphorylates mitochondrial p53 to promote anti-apoptotic responses.
• Inhibits separase activity in mouse oocyte meiosis I to prevent premature chromosome segregation.
• Oxidative stress-induced unscheduled activity impairs ER-mitochondria bioenergetics.
• Nuclear localization and upstream regulators control its substrate specificity.
• Dysregulation is linked to cancer, aneuploidy, and metabolic disorders.
• Serves as a model for cyclin-dependent kinase regulation and drug discovery.
What Happens During cyclin B1-CDK1 complex?
Activation and centrosomal appearance in prophase
In simple terms: The complex switches on at the centrosome as cells prepare to divide.
Active cyclin B1-Cdk1 first appears on centrosomes in prophase, marking the onset of mitotic commitment. This spatial activation is critical for timely centrosome separation and spindle assembly.
Sustained activity after centrosome separation
In simple terms: The complex keeps working after the centrosomes split to push mitosis forward.
Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression, ensuring that downstream mitotic events occur in the correct order.
Spindle checkpoint regulation
In simple terms: The complex helps the cell check that chromosomes are properly attached before division.
Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint, thereby preventing premature anaphase onset.
Mitochondrial respiration and anti-apoptotic signaling
In simple terms: The complex also talks to mitochondria to keep cells alive and energized during division.
Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression. It also phosphorylates mitochondrial p53 to induce an anti-apoptotic response, linking cell-cycle progression to survival signaling.
Meiotic regulation in oocytes
In simple terms: In egg cells, the complex controls when chromosomes separate.
The cyclin B2/CDK1 complex, closely related to cyclin B1-CDK1, inhibits separase activity in mouse oocyte meiosis I, highlighting the importance of CDK1-cyclin complexes in preventing aneuploidy.
Key Genes Involved in GO:0097125 cyclin B1-CDK1 complex
The following genes and proteins are central to the composition, regulation, and function of the cyclin B1-CDK1 complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCNB1 | Regulatory subunit cyclin B1; binds and activates CDK1 | Target for cell-cycle and cancer studies |
| CDK1 | Catalytic subunit; serine/threonine kinase | Core kinase for mitotic entry and progression |
| CCNB2 | Regulatory subunit cyclin B2; forms related complexes | Inhibits separase in oocyte meiosis I |
| MAD1L1 | Spindle checkpoint protein; released by cyclin B1-Cdk1 | Checkpoint robustness |
| TP53 | Tumor suppressor; phosphorylated by cyclin B1/Cdk1 on mitochondria | Anti-apoptotic signaling |
| SEPARASE | Separase; inhibited by CDK1-cyclin complexes | Chromosome segregation |
| ESPL1 | Separase gene; regulated by CDK1 phosphorylation | Meiotic and mitotic regulation |
| WEE1 | Kinase that inhibits CDK1 | Upstream regulator of cyclin B1-CDK1 |
| CDC25 | Phosphatase that activates CDK1 | Upstream regulator of cyclin B1-CDK1 |
| PLK1 | Polo-like kinase 1; interacts with cyclin B1-CDK1 | Mitotic progression |
| AURKA | Aurora kinase A; centrosome maturation | Centrosomal activation |
| MAD2L1 | Spindle checkpoint protein | Checkpoint signaling |
| BUB1 | Spindle checkpoint kinase | Checkpoint signaling |
| MCL1 | Anti-apoptotic Bcl-2 family member | Mitochondrial survival |
| DRP1 | Mitochondrial fission protein | Mitochondrial dynamics |
| TFAM | Mitochondrial transcription factor A | Mitochondrial respiration |
| GAPDH | Glycolytic enzyme; also has nuclear functions | Metabolic coordination |
How Is cyclin B1-CDK1 complex Regulated?
Cyclin B1-CDK1 complex activity is regulated by multiple mechanisms. Nuclear localization and upstream regulators such as WEE1 and CDC25 control the timing and location of activation. Oxidative stress can induce unscheduled CDK1-cyclin B1 activity, which impairs ER-mitochondria-mediated bioenergetic metabolism. The complex also participates in feedback loops with the spindle checkpoint to ensure robust mitotic progression.
cyclin B1-CDK1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCNB1 | Cancer proliferation and apoptosis resistance | Knockout and overexpression in cancer cell lines |
| CDK1 | Mitotic defects and cancer | Point mutation of kinase domain; knock-in of analog-sensitive allele |
| CCNB2 | Oocyte aneuploidy | Knockout in mouse oocytes |
| TP53 | Anti-apoptotic signaling in cancer | Phospho-mutant knock-in of p53 at CDK1 sites |
| MAD1L1 | Spindle checkpoint defects | Knockout and rescue with phospho-mutants |
Cancer
Overexpression or hyperactivation of cyclin B1-CDK1 is frequently observed in cancers, where it drives uncontrolled proliferation and resistance to apoptosis. The complex phosphorylates mitochondrial p53 to promote anti-apoptotic responses, contributing to tumor survival. Targeting cyclin B1-CDK1 is therefore a promising therapeutic strategy.
Oocyte aneuploidy and reproductive disorders
In mouse oocytes, the related cyclin B2/CDK1 complex inhibits separase activity during meiosis I, and its dysregulation can lead to premature chromosome segregation and aneuploidy. This highlights the importance of CDK1-cyclin complexes in reproductive health.
Metabolic and mitochondrial dysfunction
Cyclin B1/Cdk1 coordinates mitochondrial respiration for G2/M progression, and oxidative stress-induced unscheduled activity impairs ER-mitochondria bioenergetics. These findings link the complex to metabolic disorders and mitochondrial diseases.
From cyclin B1-CDK1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of CDK1 kinase activity in mitosis? | Knockout of CDK1 or point mutation of catalytic residues |
| How does cyclin B1 phosphorylation of p53 affect apoptosis? | Knock-in of phospho-deficient p53 mutants |
| Where and when is cyclin B1-CDK1 active in live cells? | Tagged knock-in of cyclin B1 or CDK1 with fluorescent proteins |
| What are the substrates of cyclin B1-CDK1? | Overexpression of constitutively active CDK1 followed by phosphoproteomics |
| How does oxidative stress affect cyclin B1-CDK1? | Point mutation of oxidative stress-responsive residues |
| What genes synergize with cyclin B1-CDK1 loss? | CRISPR library screening in knockout backgrounds |
How to Study the cyclin B1-CDK1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Subcellular localization and dynamics | Centrosomal and mitochondrial activation |
| Phosphoproteomics | Global phosphorylation changes | Substrate identification |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Target discovery |
| Kinase assay | Enzymatic activity | Inhibitor testing |
| Proximity ligation assay | Protein-protein interactions | Complex assembly |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Metabolic flux analysis | Mitochondrial respiration | Bioenergetics |
| Flow cytometry | Cell cycle profiling | G2/M arrest |
Live-cell imaging of cyclin B1-CDK1 dynamics
Fluorescently tagged cyclin B1 or CDK1 knock-in cell lines allow real-time visualization of complex localization and activation at centrosomes and mitochondria.
Phosphoproteomics for substrate identification
Mass spectrometry-based phosphoproteomics after CDK1 activation or inhibition reveals direct substrates and downstream signaling networks.
CRISPR screening for genetic interactions
Genome-wide CRISPR knockout or activation screens in cells with altered cyclin B1-CDK1 activity identify synthetic lethal partners and resistance mechanisms.
Biochemical kinase assays
In vitro kinase assays using recombinant cyclin B1-CDK1 and substrate peptides measure catalytic activity and inhibitor efficacy.
How CRISPR Can Be Used to Study GO:0097125 cyclin B1-CDK1 complex
Knockout
CRISPR knockout of CDK1 or CCNB1 eliminates cyclin B1-CDK1 complex function, causing cell cycle arrest and revealing essential roles in mitosis. Knockout models are used to study proliferation defects and to identify compensatory pathways.
Point Mutation
Point mutations in the catalytic domain of CDK1 or in cyclin B1 phosphorylation sites allow precise dissection of kinase activity and substrate specificity without altering protein levels.
Knock-in
Knock-in of fluorescent tags or analog-sensitive alleles enables live-cell imaging and chemical genetics, providing spatial and temporal control of cyclin B1-CDK1 activity.
Overexpression
Overexpression of cyclin B1 or constitutively active CDK1 induces unscheduled mitotic entry and can model cancer-associated hyperactivation, useful for drug screening.
How EDITGENE Supports cyclin B1-CDK1 complex Research
Researchers studying cyclin B1-CDK1 complex-related genes often need to determine whether a candidate gene is causally involved in mitotic regulation, metabolic coordination, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for cyclin B1-CDK1 complex research.
Frequently Asked Questions About cyclin B1-CDK1 complex
What is the cyclin B1-CDK1 complex?
The cyclin B1-CDK1 complex (GO:0097125) is a heterodimeric protein complex composed of cyclin B1 and CDK1 that drives mitotic entry and progression.
What genes are involved in the cyclin B1-CDK1 complex?
Key genes include CCNB1 (cyclin B1), CDK1, and related regulators such as WEE1, CDC25, and MAD1L1.
Where is the cyclin B1-CDK1 complex located in the cell?
It localizes to centrosomes, cytoplasm, nucleus, and mitochondria, with active pools first appearing on centrosomes in prophase.
What is the function of cyclin B1-CDK1 in mitosis?
It phosphorylates multiple substrates to control centrosome separation, spindle assembly, chromosome segregation, and mitotic exit.
How is cyclin B1-CDK1 activity regulated?
It is regulated by nuclear localization, upstream kinases and phosphatases like WEE1 and CDC25, and oxidative stress.
What diseases are associated with cyclin B1-CDK1 dysfunction?
Dysregulation is linked to cancer, oocyte aneuploidy, and metabolic/mitochondrial disorders.
How can I study cyclin B1-CDK1 using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional interrogation of the complex.
What methods are used to measure cyclin B1-CDK1 activity?
Common methods include live-cell imaging, phosphoproteomics, kinase assays, and CRISPR screens.
Is cyclin B1-CDK1 a good cancer drug target?
Yes, its role in proliferation and apoptosis resistance makes it a promising target, though normal cell toxicity must be considered.
What is the difference between cyclin B1-CDK1 and cyclin B2-CDK1?
Cyclin B1-CDK1 is the primary mitotic kinase, while cyclin B2-CDK1 has specialized roles in meiosis and is less studied.
Conclusion
The cyclin B1-CDK1 complex (GO:0097125) is a central regulator of mitosis, coordinating centrosome function, spindle checkpoint signaling, mitochondrial respiration, and cell survival. Its precise regulation is critical for normal cell division, and its dysregulation contributes to cancer, aneuploidy, and metabolic disorders. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate its roles and therapeutic potential.
References
- 1. Li J et al.. 2019. The cyclin B2/CDK1 complex inhibits separase activity in mouse oocyte meiosis I.. Development 146(23) PMID: 31704793
- 2. Chang JG et al.. 2021. Oxidative Stress-Induced Unscheduled CDK1-Cyclin B1 Activity Impairs ER-Mitochondria-Mediated Bioenergetic Metabolism.. Cells 10(6) PMID: 34064109
- 3. Porter LA et al.. 2003. Cyclin B1 and CDK1: nuclear localization and upstream regulators.. Prog Cell Cycle Res 5:335-47 PMID: 14593728
- 4. Jackman M et al.. 2003. Active cyclin B1-Cdk1 first appears on centrosomes in prophase.. Nat Cell Biol 5(2):143-8 PMID: 12524548
- 5. Lindqvist A et al.. 2007. Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression.. PLoS Biol 5(5):e123 PMID: 17472438
- 6. Wang Z et al.. 2014. Cyclin B1/Cdk1 coordinates mitochondrial respiration for cell-cycle G2/M progression.. Dev Cell 29(2):217-32 PMID: 24746669
- 7. Jackman M et al.. 2020. Cyclin B1-Cdk1 facilitates MAD1 release from the nuclear pore to ensure a robust spindle checkpoint.. J Cell Biol 219(6) PMID: 32236513
- 8. Nantajit D et al.. 2010. Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response.. PLoS One 5(8):e12341 PMID: 20808790
